Fiche du document
6 septembre 2023
- doi: 10.53738/REVMED.2023.19.840.1627
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.840.1627
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37671764
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_251A11C0A5B96
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2025-03-06 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
General practitioners General practice (Medicine)Citer ce document
J.D. Leuppi et al., « BPCO : une maladie encore négligée [COPD : a still neglected condition] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.840.1627
Métriques
Partage / Export
Résumé
Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung disorder with a complex clinical picture. The diagnosis may be difficult at times, as COPD may develop insidiously and remain unnoticed for a long time. Therefore, general practitioners play a central role in early detection of disease. Suspected COPD may be confirmed by further investigations in collaboration with a pulmonologist. The most recent GOLD guideline defines three COPD risk groups (A-B-E) which should guide the personalized treatment concept. General practitioners are crucial for implementing non-pharmacological measures such as smoking cessation, regular exercise, vaccinations, and patient self-management education. However, this also underlines the challenges to implement the GOLD recommendations in daily practice.